Autres langues Genflow Biosciences plc

Actions

GENF

GB00BP2C3V08

Temps Différé London S.E. Autres places de cotation 11:03:08 13/06/2024			Varia. 5j.	Varia. 1 janv.
3,3 ^GBX	-0,00 %		+6,45 %	+131,57 %

12/06	RÉSULTATS ET TRANSACTIONS : La perte de Distil se creuse ; Genflow se félicite de l'octroi d'une subvention	AN
30/05	Genflow Biosciences reçoit 50% de la subvention pour son projet sur la sarcopénie	AN

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

EARNINGS AND TRADING: Distil loss widens; Genflow welcomes grant	12/06
Genflow Biosciences receives 50% of grant for sarcopenia project	30/05
Genflow Biosciences Secures Grant for Sarcopenia Research Program	30/05
Genflow Biosciences advances three major programs in fight against ageing diseases	09/05
Home REIT cuts borrowings, Genflow shares restored	08/05
Genflow Biosciences Resumes London Trading	08/05
EARNINGS AND TRADING: Solid State and MTI Wireless win deals	07/05
Genflow Biosciences plc Reports Earnings Results for the Full Year Ended December 31, 2023	07/05
Genflow Biosciences to Temporarily Halt Trading Amid Delay in FY23 Results Publication	01/05
Genflow Biosciences attracts new institutional investors with £715,000 fundraise	08/04
Northcoders launches bootcamp; Schroder invests	04/04
Genflow Biosciences Raises New Funds for Liver Disease Treatment Trials	04/04
Genflow confirms publication of European patent for SIRT6	21/03
Genflow Biosciences Plc to Present Live at the Virtual Life Science Investor Forum March 7th	05/03
Genflow Biosciences Releases 2023 Year-End Review and Highlights Key Priorities for 2024	07/02
Genflow wins new research grants; Seeen margin rises	01/02
Genflow Biosciences Releases 2023 Year-End Review and Highlights Key Priorities for 2024	01/02
Genflow Biosciences Releases 2023 Year-End Review and Highlights Key Priorities for 2024	01/02
Coro Energy strikes finance deal in Vietnam	18/01
Genflow Biosciences Partners with Revatis SA and EXO Biologics in Groundbreaking Aging Research, Fueled by Two Major Research Grants	18/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Genflow Biosciences plc

Actions

GENF

GB00BP2C3V08

Autres langues

Filtres